We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Urine Test Diagnoses Early-Stage Prostate Cancer

By LabMedica International staff writers
Posted on 01 May 2025

Prostate cancer is one of the leading causes of death among men worldwide. More...

A major challenge in diagnosing the disease is the absence of reliable biomarkers that can detect early-stage tumors. Now, a study published in Cancer Research reveals that prostate cancer can be diagnosed at an early stage using a simple urine sample.

Researchers from Karolinska Institutet (Stockholm, Sweden), utilizing artificial intelligence (AI) and comprehensive analyses of gene activity in prostate tumors, have discovered new biomarkers with high diagnostic accuracy. By analyzing the mRNA activity of all human genes in thousands of individual cells within prostate tumors, and considering the location and degree of cancer in each cell, the researchers were able to develop digital models of prostate cancer. These models were then analyzed with AI to identify proteins that could serve as biomarkers. The identified biomarkers were subsequently tested in the blood, prostate tissue, and urine of nearly 2,000 patients.

The team discovered a set of biomarkers in urine that could accurately indicate both the presence and severity of prostate cancer. According to their findings, these biomarkers outperform PSA, the blood biomarker currently used in clinical practice. The next phase of research involves large-scale clinical trials to further validate these results. More precise biomarkers than PSA could lead to earlier detection and better prognoses for men with prostate cancer. Additionally, they could help reduce the number of unnecessary prostate biopsies in healthy men.

“There are many advantages to measuring biomarkers in urine,” explains principal investigator Mikael Benson, senior researcher at the Department of Clinical Science, Intervention and Technology, Karolinska Institutet. “It’s non-invasive and painless and can potentially be done at home. The sample can then be analyzed using routine methods in clinical labs.”


New
Gold Member
Latex Test
SLE-Latex Test
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Enterovirus Test
Quanty Enterovirus System
New
Giardia Assay
AccuDiag Giardia
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Ear wax could be a possible screening medium for Parkinson’s disease (Photo courtesy of 123RF)

Earwax Test Accurately Detects Parkinson’s by Identifying Odor Molecules

Current tests for Parkinson’s disease (PD) rely heavily on clinical scales and neuroimaging, which are often subjective, expensive, and ill-suited for routine screening. Since most treatments only slow... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: T cell immunity could be a marker for early Parkinson’s treatment (Photo courtesy of Shutterstock)

T Cells in Blood Can Detect Parkinson's Years Before Diagnosis

Diagnosing Parkinson’s disease before the appearance of motor symptoms remains one of neurology’s most significant challenges. Patients can go years—even decades—without a diagnosis, as subtle early indicators... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.